查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1808595

再生医学人工智慧市场（按技术、功能、发展阶段、产品、应用和最终用户产业）—2025-2030 年全球预测

Artificial Intelligence in Regenerative Medicine Market by Technology, Functionality, Stage Of Development, Offerings, Application, End-User Industry - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

再生医学人工智慧市场规模预计2024年将达到2.9423亿美元，2025年将达到3.5793亿美元，2030年将达到9.7813亿美元，复合年增长率为22.16%。

主要市场统计数据
基准年2024年 2.9423亿美元
预计2025年 3.5793亿美元
预测年份 2030 9.7813亿美元
复合年增长率（%） 22.16%

探索人工智慧与再生医学的交会点，推动以病人为中心的突破性治疗

人工智慧正在重新定义再生医学的边界，它使细胞和组织工程达到前所未有的精准度，加速探索，并优化治疗效果。先进的计算建模与生物学研究的融合，正在开启一个患者专属解决方案的新时代，在这个时代，数位平台将指导新型支架的设计、预测细胞行为并优化递送机制。本介绍将全面探讨演算法驱动的工具如何与实验室流程结合，以增强再生介入的有效性和安全性。

检验模式转移技术与临床进展，重新定义再生医学治疗通讯协定

运算能力的迅猛增长和演算法的日益复杂，正在彻底改变再生医学的格局。过去十年，影像处理的进步使研究人员能够以微观精度绘製组织结构图，视讯分析平台也使得即时捕捉细胞动态事件成为可能。同时，深度学习框架在解读基因组和蛋白质组资料集方面展现出令人印象深刻的能力，为基因调控和细胞重编程开闢了新的标靶。

评估美国2025年关税调整对人工智慧主导的再生医学领域的累积影响

美国将于2025年起实施新关税，增加了采购硬体组件、先进影像处理设备和专用试剂的复杂性，而这些对于人工智慧主导的再生研究至关重要。进口高解析度显微镜和计算加速器的关税上调导致供应商合约被重新审查，促使许多实验室重新评估其长期筹资策略，以确保其营运的连续性。

透过再生医学人工智慧应用中的综合多维分割框架揭示关键见解

全面的細項分析揭示了人工智慧再生医学市场在多个维度上的深刻洞察。从底层技术的角度来看，电脑视觉（包括影像处理和视讯分析）的进步与机器学习演算法的突破同步。机器学习演算法包括深度学习、强化学习、监督学习和非监督学习，每种演算法都为复杂的生物现象建模贡献了独特的能力。语音辨识和文字分析等自然语言处理技术的结合进一步增强了数据集成，而机器人技术则充当了将电脑指令带入实验室环境的物理介面。

突显重点区域丛集的区域动态和成长模式，促进人工智慧在再生医学研究中的整合

区域分析揭示了技术采用和协作研究生态系统的多样化模式。在美洲，公共和私营部门对人工智慧基础设施和再生医学的强劲投资创造了强劲的创新环境，美国的主要枢纽推动了开创性的临床研究和产业合作。相反，欧洲、中东和非洲地区呈现出成熟度水准的混合体，西欧成熟的学术丛集与中东和北非新兴的卓越中心并存，凸显了向跨境联盟和监管协调倡议的转变。

介绍塑造全球人工智慧再生治疗解决方案未来的关键创新者和策略合作者

透过将平台创新与策略伙伴关係相结合，领先企业和先锋新兴企业正在探索人工智慧整合再生医学的新领域。领先的科技公司正在与细胞治疗专家合作，共同开发数据驱动的诊断工具，而成熟的生物製药公司则正在投资机器学习新兴企业，以增强标靶发现并简化生产流程。同时，生物技术创新者正在将其专有演算法授权给学术中心，建构共用智慧财产权的生态系统，以加速共同进步。

为产业主管提供可行的策略蓝图，利用再生医学领域的人工智慧创新来获得竞争优势

寻求利用人工智慧与再生医学整合的产业领导者必须制定以资料准备、跨职能协作和敏捷监管参与为中心的策略蓝图。首先，他们必须投资可扩展、安全的资料基础设施，以容纳多样化的生物医学资料集，并支援进阶模型训练，同时又不影响合规性。此外，他们必须培养由生物工程师、资料科学家、临床医生和监管专家组成的多学科团队，以弥合知识孤岛，并加快转化里程碑的实现。

了解我们强大的研究途径，将定量分析与定性见解相结合，以确保数据的完整性和深度

调查方法采用严格的多阶段方法，旨在确保全面覆盖和资料完整性。研究流程始于结构化的二次研究阶段，涵盖同侪审查出版品、临床试验註册库、专利资料库和监管文件。从这些资讯来源获得的洞见为制定详细的资料收集框架提供了依据，随后开展了一次研究，包括与来自学术界、临床机构和商业公司的关键意见领袖、行业资深人士、技术架构师和最终用户代表进行深入访谈。

综合主要研究结果，强调人工智慧在全球再生医学治疗方法发展中的变革作用

这项全面的分析综合报告凸显了人工智慧在加速探索、优化临床工作流程和拓展再生医学前沿方面的变革潜力。先进的影像处理和预测分析技术能够精确表征细胞动力学，而自适应学习系统则能够即时优化治疗通讯协定。软体创新者与生物技术公司之间的合作正在创建整合平台，以支援从实验室研究到临床部署的决策。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章市场动态

  • 用于动态调整再生製造中生物过程程式参数的强化学习框架
  • 基于电脑视觉的自动再生製造中细胞培养过程的即时监控
  • 人工智慧驱动的干细胞分化途径预测模型，用于个人化组织再生
  • 使用人工智慧增强影像分析即时监测组织再生
  • 基于深度学习的3D生物列印参数最佳化，用于製造复杂器官支架
  • 机器学习演算法增强生物材料设计，改善支架的生物相容性和功能
  • 将数位双胞胎平台与人工智慧结合，模拟特定患者的再生治疗结果
  • 用于再生医学研究流程中自动文献综述的自然语言处理工具
  • 人工智慧驱动的生物标记发现，用于客製化组织修復中的免疫调节疗法
  • 数位双胞胎模拟预测类器官生长模式和治疗结果

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

第八章再生医学人工智慧市场（按技术）

  • 电脑视觉
    • 影像处理
    • 影片分析
  • 机器学习演算法
    • 深度学习
    • 强化学习
    • 监督学习
    • 无监督学习
  • 自然语言处理
    • 语音辨识
    • 文字分析
  • 机器人技术

第九章再生医学人工智慧市场：功能

  • 决策支援系统
  • 预测分析
  • 优化您的工作流程

第 10 章再生医学人工智慧市场（按发展阶段）

  • 临床试验
  • 临床前

第 11 章再生医学人工智慧市场（按类型）

  • 服务
    • 咨询与实施
    • 维护和支援
  • 软体
    • 人工智慧演算法和平台
    • 数据分析和视觉化工具

第 12 章再生医学人工智慧市场（按应用）

  • 心血管疾病
    • 心肌梗塞的治疗
    • 血管组织修復
  • 神经病学
    • 神经退化性疾病
    • 修復创伤性脑损伤
  • 肿瘤学
    • 癌症疫苗
    • 基因转移疗法
  • 眼科
    • 角膜修復
    • 视网膜疾病治疗
  • 整形外科
    • 骨再生
    • 软骨修復
    • 脊椎疾病的治疗

第 13 章 再生医学人工智慧市场（按最终用户产业）

  • 学术研究机构
  • 医院和诊所
  • 製药和生物技术公司

14. 美国医疗机构人工智慧市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

第 15 章欧洲、中东和非洲再生医学人工智慧市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

16. 亚太地区再生医学人工智慧市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十七章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Aiforia Technologies Plc
    • Aspen Neuroscience
    • Celularity Inc.
    • Deep Genomics Incorporated
    • Epistra Inc.
    • Exscientia plc
    • F. Hoffmann-La Roche Ltd.
    • Insilico Medicine
    • Intel Corporation
    • Juvenescence Therapeutics Limited
    • Medtronic PLC
    • Merck KGaA
    • Microsoft Corporation
    • Novo Nordisk A/S
    • NVIDIA Corporation
    • Owkin, Inc
    • Pandorum Technologies Pvt. Ltd
    • Recursion Pharmaceuticals
    • Sanofi SA
    • SOMITE THERAPEUTICS.
    • Tempus Labs, Inc.
    • Wipro Limited

第十八章 研究人工智慧

第十九章 研究统计

第二十章 研究联络人

第21章 研究报导

第22章 附录

Product Code: MRR-A6768A62EE02

The Artificial Intelligence in Regenerative Medicine Market was valued at USD 294.23 million in 2024 and is projected to grow to USD 357.93 million in 2025, with a CAGR of 22.16%, reaching USD 978.13 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 294.23 million
Estimated Year [2025] USD 357.93 million
Forecast Year [2030] USD 978.13 million
CAGR (%) 22.16%

Unveiling the Intersection of Artificial Intelligence and Regenerative Medicine to Propel Revolutionary Patient-Centric Therapies

Artificial intelligence is redefining the boundaries of regenerative medicine by enabling unprecedented precision in cell and tissue engineering, accelerating discovery, and optimizing therapeutic outcomes. The convergence of advanced computational models with biological research has ushered in a new era of patient-specific solutions, where digital platforms guide the design of novel scaffolds, predict cell behavior, and refine delivery mechanisms. This introduction sets the stage for a comprehensive exploration of how algorithm-driven tools integrate with laboratory processes to amplify the efficacy and safety of regenerative interventions.

By harnessing sophisticated pattern recognition capabilities, researchers are now able to decode complex cellular interactions in ways that were previously unattainable. Visual computing systems transform microscopic imagery into actionable data, while adaptive learning algorithms continuously refine predictions based on new experimental results. Furthermore, robotics-mediated automation streamlines labor-intensive workflows, freeing scientific teams to focus on strategic innovation rather than repetitive tasks.

As this report unfolds, you will discover how these synergistic technologies coalesce to build a robust infrastructure for regenerative medicine. From initial proof-of-concept studies through late-stage clinical evaluations, the integration of AI lays a foundation for scalable manufacturing, regulatory compliance, and personalized treatment modalities that hold the promise of transforming patient care on a global scale.

Examining the Paradigm-Shifting Technological and Clinical Advances That Are Redefining Treatment Protocols in Regenerative Medicine

The landscape of regenerative medicine has undergone transformative shifts driven by breakthroughs in computational power and algorithmic sophistication. Over the past decade, image processing innovations have enabled researchers to map tissue architectures with microscopic accuracy, while video analysis platforms have captured dynamic cellular events in real time. Simultaneously, deep learning frameworks have demonstrated remarkable proficiency in deciphering genomic and proteomic datasets, unlocking new targets for gene modulation and cellular reprogramming.

Natural language processing has revolutionized literature mining, facilitating rapid synthesis of research findings and enabling automated hypothesis generation from vast repositories of scientific publications. Voice-enabled interfaces now support hands-free laboratory control, enhancing efficiency in sterile environments. On the manufacturing front, robotics integration has matured, offering high-throughput bioprinting capabilities that produce consistent tissue constructs at scale.

These technological advancements have not only accelerated R&D timelines but have also redefined collaboration paradigms. Multidisciplinary teams now leverage decision support systems that merge predictive analytics with domain expertise. Workflow optimization engines dynamically allocate resources, reducing bottlenecks and improving reproducibility. As regulatory agencies increasingly recognize the crucial role of these tools, adaptive approval pathways are emerging, setting the stage for wider clinical adoption of AI-enabled regenerative therapies.

Assessing the Cumulative Consequences of United States 2025 Tariff Adjustments on the Artificial Intelligence-Driven Regenerative Medicine Sector

The implementation of new tariff measures in the United States from 2025 onward has introduced additional layers of complexity to the procurement of critical hardware components, advanced imaging devices, and specialized reagents pivotal to AI-driven regenerative research. Elevated duties on imported high-resolution microscopes and computing accelerators have led to recalibrated vendor contracts, prompting many laboratories to reevaluate long-term procurement strategies in an effort to safeguard operational continuity.

Over time, stakeholders have witnessed a cumulative impact that extends beyond immediate cost escalations. Collaborative projects between academic research centers and global technology providers have encountered negotiation delays as pricing structures are adjusted. Some organizations have responded by increasing domestic sourcing or by forging alliances with local manufacturers capable of delivering compliant instrumentation at competitive rates. However, these shifts have also constrained access to niche components that remain scarce in domestic markets.

In parallel, startups in the AI-regenerative medicine nexus are reassessing capital allocation toward infrastructure investments, mindful of the risk associated with fluctuating international trade policies. As a consequence, many venture-backed enterprises are accelerating efforts to develop in-house capabilities for data annotation, algorithmic training, and prototype fabrication, reducing reliance on imported modules. Looking ahead, industry leaders must navigate this evolving tariff environment by cultivating diversified supplier networks and leveraging policy advocacy to mitigate supply chain vulnerabilities.

Uncovering Critical Insights Through a Comprehensive Multi-Dimensional Segmentation Framework in Regenerative Medicine AI Applications

A thorough segmentation analysis reveals nuanced insights across multiple dimensions of the AI-enabled regenerative medicine market. When viewed through the lens of underlying technology, it becomes evident that advances in computer vision, which encompass both image processing and video analysis, have been paralleled by breakthroughs in machine learning algorithms. The latter category comprises deep learning, reinforcement learning, supervised learning, and unsupervised learning, each contributing distinct capabilities to model complex biological phenomena. Incorporation of natural language processing techniques such as speech recognition and text analysis further enhances data integration, while robotics serves as the physical interface that brings computational directives into the laboratory setting.

Evaluating functionality demonstrates that decision support systems, predictive analysis modules, and workflow optimization tools are increasingly indispensable for research and clinical operations. These platforms streamline critical decision pathways, offering dynamic recommendations that reduce trial-and-error cycles. Across stages of development, ongoing preclinical investigations feed data-driven hypotheses into clinical trials, establishing a feedback loop that accelerates translational progress.

Insights into product offerings indicate that service-based solutions-ranging from consulting and implementation to maintenance and support-are complemented by software packages built on AI algorithms, platforms, and data analytics and visualization tools. This duality ensures clients receive end-to-end support, from initial deployment through iterative enhancements. Finally, practical applications span major therapeutic areas including cardiovascular diseases with a focus on myocardial infarction therapy and vascular tissue repair, neurology targeting neurodegenerative disorders and traumatic brain injury repair, oncology through cancer vaccines and gene transduction therapies, ophthalmology addressing corneal repair and retinal disease therapy, and orthopedics encompassing bone regeneration, cartilage repair, and spinal disorder treatments. End-user industries for these solutions include academic and research institutes, hospitals and clinics, and pharmaceutical and biotechnology companies, each leveraging AI-driven insights to advance their unique missions.

Highlighting Regional Dynamics and Growth Patterns Across Key Territory Clusters Driving AI Integration in Regenerative Medicine Research

Regional analysis uncovers diverse patterns of technology adoption and collaborative research ecosystems. In the Americas, strong public and private investment in both AI infrastructure and regenerative medicine has created a robust innovation climate, with major hubs in the United States driving trailblazing clinical studies and industrial partnerships. Conversely, European, Middle Eastern, and African regions exhibit a mosaic of maturity levels, where established academic clusters in Western Europe coexist with emerging centers of excellence in the Middle East and North Africa, underscoring a shift toward cross-border consortia and regulatory harmonization initiatives.

Meanwhile, Asia-Pacific markets demonstrate rapid expansion fueled by government-sponsored research programs and growing biomanufacturing capacities. Nations in East Asia are advancing high-throughput bioprinting and cell therapy platforms, while Southeast Asian countries are leveraging cost-effective clinical trial sites to attract international collaborations. Taken together, these regional dynamics highlight a global convergence toward shared best practices, multi-stakeholder funding models, and harmonized data governance frameworks that accelerate the translation of AI-powered regenerative therapies from lab to clinic.

As research networks strengthen their cross-continental ties, manufacturers and technology providers are aligning distribution strategies and forging licensing agreements to ensure timely delivery of critical components. These synergistic efforts underscore the importance of regional insight when charting strategic market entry and expansion plans.

Profiling the Leading Innovators and Strategic Collaborators Shaping the Future of AI-Enabled Regenerative Therapeutic Solutions Globally

Leading corporations and pioneering startups are forging a new frontier in AI-integrated regenerative medicine by combining platform innovations with strategic partnerships. Major technology firms are collaborating with cell therapy specialists to co-develop data-driven diagnostic tools, while established biopharmaceutical companies invest in machine learning startups to bolster target discovery and streamline manufacturing pipelines. At the same time, biotech innovators are licensing proprietary algorithms to academic centers, creating an ecosystem where shared intellectual assets accelerate collective progress.

These strategic collaborations extend into multi-institutional alliances that integrate complementary strengths: computational design houses contributing algorithmic expertise connect with contract development organizations offering bioprocessing capabilities, forging end-to-end value chains. Moreover, recent mergers and acquisitions have reshaped the competitive landscape, enabling some players to vertically integrate AI analytics, cloud infrastructure, and cell culture facilities under a single organizational umbrella. This consolidation trend is complemented by consortium-based initiatives that democratize access to high-performance computing and standardized datasets, mitigating barriers for emerging entrants.

As capital continues to flow into this intersection of AI and regenerative medicine, corporate strategies are evolving to emphasize ecosystem development over product-centric approaches. By nurturing collaborative networks, these companies are not only accelerating innovation cycles but also establishing robust intellectual property portfolios that set the stage for long-term market leadership.

Actionable Strategic Roadmap for Industry Executives to Harness AI Innovations in Regenerative Medicine for Competitive Advantage

Industry leaders seeking to capitalize on the convergence of artificial intelligence and regenerative medicine must adopt a strategic roadmap centered on data readiness, cross-functional collaboration, and agile regulatory engagement. First, they should invest in scalable, secure data infrastructure that accommodates diverse biomedical datasets and supports advanced model training without compromising compliance. Coupled with this, organizations need to cultivate cross-disciplinary teams comprising bioengineers, data scientists, clinicians, and regulatory experts to bridge knowledge silos and expedite translational milestones.

Concurrently, proactive engagement with regulatory bodies can shape adaptive oversight frameworks that foster innovation while ensuring patient safety. Companies are advised to participate in pilot programs and public-private partnerships that co-create guidelines for AI-driven medical devices and biologics. By doing so, stakeholders can influence standards, gain early feedback, and reduce time-to-market for novel therapies.

Finally, forging ecosystem partnerships-whether through consortium memberships, joint ventures, or licensing agreements-will be crucial to access complementary capabilities. Aligning with academic institutions or technology providers can unlock specialized expertise, shared infrastructure, and co-investment opportunities. Through these deliberate actions, executives will position their organizations to harness AI innovations effectively, drive competitive differentiation, and ultimately deliver transformative therapeutic solutions to patients.

Detailing a Robust Research Approach Integrating Quantitative Analyses and Qualitative Insights to Ensure Data Integrity and Depth

This research integrates a rigorous multi-phased methodology designed to ensure comprehensive coverage and data integrity. The process commenced with a structured secondary research phase, encompassing peer-reviewed publications, clinical trial registries, patent databases, and regulatory filings. Insights gleaned from these sources informed the development of a detailed data collection framework, followed by primary research comprising in-depth interviews with key opinion leaders, industry veterans, technology architects, and end-user representatives across academia, clinical settings, and commercial enterprises.

Quantitative analyses were conducted using advanced statistical techniques and machine learning-based data modeling, enabling robust identification of correlations, trend extrapolations, and scenario simulations. Qualitative evaluation complemented these findings through thematic coding of interview transcripts and case study analyses, illuminating contextual factors and strategic considerations that numbers alone cannot capture. Triangulation across secondary sources, primary insights, and analytical models further validated results and illuminated areas of convergence or discrepancy.

Throughout the process, stringent quality control measures-such as peer reviews, audit trails, and consistency checks-ensured the credibility and reproducibility of the findings. This integrated research design provides stakeholders with a transparent, evidence-based foundation for informed decision-making within the rapidly evolving intersection of AI and regenerative medicine.

Synthesizing Key Findings to Illuminate the Transformational Role of AI in Advancing Regenerative Medicine Therapeutic Modalities Globally

The synthesis of this comprehensive analysis underscores the transformational potential of artificial intelligence to accelerate discovery, optimize clinical workflows, and expand the frontiers of regenerative medicine. Advanced image processing and predictive analytics are enabling precise characterization of cellular dynamics, while adaptive learning systems refine therapeutic protocols in real time. Collaboration between software innovators and biotech organizations is yielding integrated platforms that support decision-making from laboratory research through clinical deployment.

Regional and tariff considerations further highlight the necessity for flexible sourcing strategies and policy engagement to sustain innovation momentum. Segmentation insights reveal that success hinges on tailored offerings that address distinct technological, functional, and developmental requirements, as well as specific therapeutic applications ranging from cardiovascular repair to neurologic and oncologic interventions. Strategic alliances and ecosystem-based approaches emerge as critical enablers, fostering shared infrastructure, co-investment, and regulatory alignment.

In conclusion, the intersection of AI and regenerative medicine represents a paradigm shift with far-reaching implications for healthcare. By embracing data-driven methodologies, fostering multidisciplinary partnerships, and navigating evolving trade environments, stakeholders can unlock unprecedented opportunities to deliver personalized, effective, and scalable therapies that improve patient outcomes globally.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Reinforcement learning frameworks to dynamically adjust bioprocess parameters in regenerative manufacturing
  • 5.2. Computer vision-based real-time monitoring of cell culture processes in automated regenerative manufacturing
  • 5.3. AI-driven predictive modeling of stem cell differentiation pathways for personalized tissue regeneration
  • 5.4. Real-time monitoring of tissue regeneration using AI-enhanced imaging analytics
  • 5.5. Deep learning-powered optimization of 3D bioprinting parameters for complex organ scaffold fabrication
  • 5.6. Machine learning algorithms enhancing biomaterials design for improved scaffold biocompatibility and function
  • 5.7. Integration of digital twin platforms with AI to simulate patient-specific regenerative therapy outcomes
  • 5.8. Natural language processing tools for automated literature review in regenerative medicine research pipelines
  • 5.9. AI powered biomarker discovery for customizing immunomodulatory treatments in tissue repair
  • 5.10. Digital twin simulations for predicting organoid growth patterns and therapeutic efficacy outcomes

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Artificial Intelligence in Regenerative Medicine Market, by Technology

  • 8.1. Introduction
  • 8.2. Computer Vision
    • 8.2.1. Image Processing
    • 8.2.2. Video Analysis
  • 8.3. Machine Learning Algorithms
    • 8.3.1. Deep Learning
    • 8.3.2. Reinforcement Learning
    • 8.3.3. Supervised Learning
    • 8.3.4. Unsupervised Learning
  • 8.4. Natural Language Processing
    • 8.4.1. Speech Recognition
    • 8.4.2. Text Analysis
  • 8.5. Robotics

9. Artificial Intelligence in Regenerative Medicine Market, by Functionality

  • 9.1. Introduction
  • 9.2. Decision Support Systems
  • 9.3. Predictive Analysis
  • 9.4. Workflow Optimization

10. Artificial Intelligence in Regenerative Medicine Market, by Stage Of Development

  • 10.1. Introduction
  • 10.2. Clinical Trials
  • 10.3. Preclinical

11. Artificial Intelligence in Regenerative Medicine Market, by Offerings

  • 11.1. Introduction
  • 11.2. Service
    • 11.2.1. Consulting & Implementation
    • 11.2.2. Maintenance & Support
  • 11.3. Software
    • 11.3.1. AI Algorithms & Platforms
    • 11.3.2. Data Analytics & Visualization Tools

12. Artificial Intelligence in Regenerative Medicine Market, by Application

  • 12.1. Introduction
  • 12.2. Cardiovascular Diseases
    • 12.2.1. Myocardial Infarction Therapy
    • 12.2.2. Vascular Tissue Repair
  • 12.3. Neurology
    • 12.3.1. Neurodegenerative Disorders
    • 12.3.2. Traumatic Brain Injury Repair
  • 12.4. Oncology
    • 12.4.1. Cancer Vaccine
    • 12.4.2. Gene Transduction Therapy
  • 12.5. Ophthalmology
    • 12.5.1. Corneal Repair
    • 12.5.2. Retinal Disease Therapy
  • 12.6. Orthopedics
    • 12.6.1. Bone Regeneration
    • 12.6.2. Cartilage Repair
    • 12.6.3. Spinal Disorders Treatment

13. Artificial Intelligence in Regenerative Medicine Market, by End-User Industry

  • 13.1. Introduction
  • 13.2. Academic & Research Institutes
  • 13.3. Hospitals And Clinics
  • 13.4. Pharmaceutical & Biotechnology Companies

14. Americas Artificial Intelligence in Regenerative Medicine Market

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. Argentina

15. Europe, Middle East & Africa Artificial Intelligence in Regenerative Medicine Market

  • 15.1. Introduction
  • 15.2. United Kingdom
  • 15.3. Germany
  • 15.4. France
  • 15.5. Russia
  • 15.6. Italy
  • 15.7. Spain
  • 15.8. United Arab Emirates
  • 15.9. Saudi Arabia
  • 15.10. South Africa
  • 15.11. Denmark
  • 15.12. Netherlands
  • 15.13. Qatar
  • 15.14. Finland
  • 15.15. Sweden
  • 15.16. Nigeria
  • 15.17. Egypt
  • 15.18. Turkey
  • 15.19. Israel
  • 15.20. Norway
  • 15.21. Poland
  • 15.22. Switzerland

16. Asia-Pacific Artificial Intelligence in Regenerative Medicine Market

  • 16.1. Introduction
  • 16.2. China
  • 16.3. India
  • 16.4. Japan
  • 16.5. Australia
  • 16.6. South Korea
  • 16.7. Indonesia
  • 16.8. Thailand
  • 16.9. Philippines
  • 16.10. Malaysia
  • 16.11. Singapore
  • 16.12. Vietnam
  • 16.13. Taiwan

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Aiforia Technologies Plc
    • 17.3.2. Aspen Neuroscience
    • 17.3.3. Celularity Inc.
    • 17.3.4. Deep Genomics Incorporated
    • 17.3.5. Epistra Inc.
    • 17.3.6. Exscientia plc
    • 17.3.7. F. Hoffmann-La Roche Ltd.
    • 17.3.8. Insilico Medicine
    • 17.3.9. Intel Corporation
    • 17.3.10. Juvenescence Therapeutics Limited
    • 17.3.11. Medtronic PLC
    • 17.3.12. Merck KGaA
    • 17.3.13. Microsoft Corporation
    • 17.3.14. Novo Nordisk A/S
    • 17.3.15. NVIDIA Corporation
    • 17.3.16. Owkin, Inc
    • 17.3.17. Pandorum Technologies Pvt. Ltd
    • 17.3.18. Recursion Pharmaceuticals
    • 17.3.19. Sanofi SA
    • 17.3.20. SOMITE THERAPEUTICS.
    • 17.3.21. Tempus Labs, Inc.
    • 17.3.22. Wipro Limited

18. ResearchAI

19. ResearchStatistics

20. ResearchContacts

21. ResearchArticles

22. Appendix

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 20. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 24. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 27. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET: RESEARCHAI
  • FIGURE 28. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET: RESEARCHSTATISTICS
  • FIGURE 29. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET: RESEARCHCONTACTS
  • FIGURE 30. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY IMAGE PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY IMAGE PROCESSING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY VIDEO ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY VIDEO ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY DEEP LEARNING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REINFORCEMENT LEARNING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REINFORCEMENT LEARNING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SUPERVISED LEARNING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SUPERVISED LEARNING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY UNSUPERVISED LEARNING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY UNSUPERVISED LEARNING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SPEECH RECOGNITION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SPEECH RECOGNITION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TEXT ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TEXT ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ROBOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ROBOTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY DECISION SUPPORT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY DECISION SUPPORT SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PREDICTIVE ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PREDICTIVE ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY WORKFLOW OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY WORKFLOW OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PRECLINICAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CONSULTING & IMPLEMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CONSULTING & IMPLEMENTATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY AI ALGORITHMS & PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY AI ALGORITHMS & PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY DATA ANALYTICS & VISUALIZATION TOOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY DATA ANALYTICS & VISUALIZATION TOOLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MYOCARDIAL INFARCTION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MYOCARDIAL INFARCTION THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY VASCULAR TISSUE REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY VASCULAR TISSUE REPAIR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TRAUMATIC BRAIN INJURY REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TRAUMATIC BRAIN INJURY REPAIR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CANCER VACCINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CANCER VACCINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY GENE TRANSDUCTION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY GENE TRANSDUCTION THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CORNEAL REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CORNEAL REPAIR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY RETINAL DISEASE THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY RETINAL DISEASE THERAPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY BONE REGENERATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY BONE REGENERATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 111. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARTILAGE REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARTILAGE REPAIR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 113. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SPINAL DISORDERS TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SPINAL DISORDERS TREATMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 115. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
  • TABLE 117. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
  • TABLE 119. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 121. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 123. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 125. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 127. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2025-2030 (USD MILLION)
  • TABLE 129. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2025-2030 (USD MILLION)
  • TABLE 131. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2025-2030 (USD MILLION)
  • TABLE 133. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 135. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 137. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 139. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, 2025-2030 (USD MILLION)
  • TABLE 141. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 143. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 145. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
  • TABLE 147. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 149. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 151. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
  • TABLE 153. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
  • TABLE 155. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
  • TABLE 157. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 159. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 160. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 161. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2024 (USD MILLION)
  • TABLE 162. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2025-2030 (USD MILLION)
  • TABLE 163. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2024 (USD MILLION)
  • TABLE 164. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2025-2030 (USD MILLION)
  • TABLE 165. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 166. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2025-2030 (USD MILLION)
  • TABLE 167. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 168. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 169. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 170. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 171. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 172. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 173. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 174. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, 2025-2030 (USD MILLION)
  • TABLE 175. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 176. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 177. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 179. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
  • TABLE 180. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
  • TABLE 181. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 182. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 183. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 184. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 185. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
  • TABLE 186. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
  • TABLE 187. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 188. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
  • TABLE 189. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 190. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
  • TABLE 191. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 192. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 193. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 194. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 195. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2024 (USD MILLION)
  • TABLE 196. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2025-2030 (USD MILLION)
  • TABLE 197. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2024 (USD MILLION)
  • TABLE 198. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2025-2030 (USD MILLION)
  • TABLE 199. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 200. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2025-2030 (USD MILLION)
  • TABLE 201. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 202. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 203. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 204. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 205. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 206. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 207. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 208. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, 2025-2030 (USD MILLION)
  • TABLE 209. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 210. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 211. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 213. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
  • TABLE 214. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
  • TABLE 215. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 216. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 217. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 218. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 219. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
  • TABLE 220. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
  • TABLE 221. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 222. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
  • TABLE 223. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
  • TABLE 224. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
  • TABLE 225. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 226. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 227. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2018-2024 (USD MILLION)
  • TABLE 228. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, 2025-2030 (USD MILLION)
  • TABLE 229. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2018-2024 (USD MILLION)
  • TABLE 230. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, 2025-2030 (USD MILLION)
  • TABLE 231. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 232. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, 2025-2030 (USD MILLION)
  • TABLE 233. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 234. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 235. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 236. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STAGE OF DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 237. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 238. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 239. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 240. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICE, 2025-2030 (USD MILLION)
  • TABLE 241. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 242. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 243. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 245. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
  • TABLE 246. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
  • TABLE 247. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 249. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 250. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 251. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
  • TABLE 252. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
  • TABLE 253. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 254. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
  • TABLE 255. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER I